en
jalali
1393
4
1
gregorian
2014
7
1
2
2
online
1
fulltext
en
Tubularized incised plate urethroplasty with or without stent in Hypospadias repair: a systematic review and meta-analysis
Numerous methods for repair of hypospadias have been introduced. The technique of Tubularized Incised Plate urethroplasty has gained widespread acceptance. In the classical method of Tubularized Incised Plate urethroplasty, to divert urine flow and preventing urethral stenosis, a stent was used, but its necessity is questionable for some surgeons.
In this paper we systematically compared the results of operations in different studies. Searching the databases such as PubMed, SCOPUS, and Google Scholar was done and articles found from January 1994 to September 2013 were included. Then articles about the impact of use or non-use of urinary catheters on surgical outcomes were analyzed.
By reviewing 168 studies related to repair of hypospadias with TIP, we selected 11 studies that met our inclusion criteria which did not use a stent. A total of 708 children had urethroplasty using the TIP method without stent. The overall complication rate such as meatal stenosis and fistula compared with stents was not significant.
It could tell us that at least in some cases especially in distal types, use of stent can be avoided, because its least benefit would be reduction of bladder spasm and urinary tract infections.
Hypospadias, Stents, Urethroplasty
2
11
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-30-22&slc_lang=en&sid=1
2014/06/18
1393/3/28
2014/08/17
1393/5/26
Seyed Abdollah
Mousavi
Department of Pediatric Surgery, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Dr.a.mosavi@gmail.com
0031947532846001004
0031947532846001004
Yes
Mohsen
Aarabi
Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran
0031947532846001005
0031947532846001005
No
en
The prophylactic effect of Lactobacillus rhamnosus GG on incidence of acute rotavirus diarrhea in children: a systematic review randomized double-blind placebo-controlled trials
Background: Rotavirus is one of the most common etiologic agent of severe acute diarrhea in infants and children which results in high mortality and morbidity globally. Prophylactic strategies are required to prevent acute rotavirus diarrhea. Recently, the beneficial effect of probiotic therapy in control of rotavirus diarrhea was noted in many investigations. This systematic review investigated the prophylactic effect of Lactobacillus rhamnosus GG on the incidence of acute rotavirus diarrhea in infants and children.
Methods: Databases including PubMed, Cochrane Controlled Trial Register (CCTR), Google Scholar, Science direct and Ovid (Wolters Kluwer health) were searched for articles and reviews from 1980–2013. Reviewers selected randomized clinical trials that met the study inclusion criteria. The outcome measures included incidence of rotavirus diarrhea, duration of diarrhea, and hospital stay.
Results: The search results included three trials with 1043 eligible patients. The results indicated that the use of Lactobacillus rhamnosus GG compared with placebo significantly affected the incidence of rotavirus diarrhea without influencing the duration of hospital stay.
Conclusion: Some studies signified the role of Lactobacillus rhamnosus GG in preventing acute rotavirus diarrhea however we did not find sufficient trials with certain method to evaluate this influence.
Lactobacillus rhamnosus GG, Prevention, Rotavirus, Diarrhea
12
20
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-260-1&slc_lang=en&sid=1
2014/06/182014/06/24
1393/4/3
2014/08/172014/08/3
1393/5/12
Elaheh
Ahmadi
Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Science, Sari, Iran
Eahmadi7@gmail.com
0031947532846001006
0031947532846001006
No
Mohammad Sadegh
Rezai
Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Science, Sari, Iran
drmsrezaii@yahoo.com
0031947532846001007
0031947532846001007
Yes
en
Incidence of neonatal hypothermia at birth in hospitals of Islamic Republic of Iran: A review
Hypothermia is an important cause of neonatal morbidity and mortality especially in low-income settings. To control this problem in countries such as Iran a full knowledge of the situation is of great importance.
A review was performed both in Persian and English, including international databases. Totally 934 articles were reviewed and finally five articles were selected. The incidence of neonatal hypothermia in different parts of Iran was reported between 7.48 to 53.3 percent.
The prevalence of neonatal hypothermia is a matter of concern and further studies are needed to determine this prevalence in all parts of Iran. Furthermore, performing more etiological investigations are recommended.
Neonatal, Newborn, Hypothermia, Prevalence, Incidence, Iran
21
30
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-47-1&slc_lang=en&sid=1
2014/06/182014/06/242014/02/26
1392/12/7
2014/08/172014/08/32014/06/3
1393/3/13
Roya
Farhadi
Antimicrobial Resistant Nosocomial Infection Research Center, Faculty of medicine, Mazandaran University of Medical Sciences, Sari, Iran
dr.royafarhadi@gmail.com
0031947532846001008
0031947532846001008
Yes
Mohammad Sadegh
Rezai
Antimicrobial Resistant Nosocomial Infection Research Center, Faculty of medicine, Mazandaran University of Medical Sciences, Sari, Iran
Drmsrezaii@yahoo.com
0031947532846001009
0031947532846001009
No
Maryam
Nakhshab
Department of Pediatrics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
pegahch@yahoo.com
0031947532846001010
0031947532846001010
No
en
Rare bleeding disorders: a narrative review of epidemiology, molecular and clinical presentations, diagnosis and treatment
Rare bleeding disorders (RBDs) are a heterogeneous group of disorders including different types of coagulation factor deficiencies. The disorders are inherited in an autosomal recessive manner with different frequencies varying from 1:500000 to 1:2000000. Patients affected with RBDs are presented with a wide spectrum of clinical manifestations ranging from mild to life threatening bleeding diathesis. These disorders are usually present in regions with high rate of parental consanguinity. Despite the rare incidence of RBDs, it is necessary for physicians to be aware of these disorders. Here we aim to have a comprehensive review on general features and also the recent advances in understanding of RBDs. MEDLINE and Web of Science databases searched for English sources from 1990 to 2014, using the following keywords: rare bleeding disorder, rare inherited disorder, factor deficiency, structure, function, epidemiology, manifestations, laboratory analysis, diagnosis, mutation, treatment, management and also all the factor deficiencies which are considered as RBD. Knowledge towards RBDs is increasing, however, most of published data are limited to small group of populations or case reports. Therefore, there are still several questions on these rare disorders which need to be clarified through large prospective studies.
Rare Diseases, Bleeding disorder, Factor, Deficiency, Epidemiology, Diagnosis, Treatment
31
46
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-255-1&slc_lang=en&sid=1
2014/06/182014/06/242014/02/262014/07/15
1393/4/24
2014/08/172014/08/32014/06/32014/07/15
1393/4/24
Majid
Naderi
Departement Of Pediatrics Hematology & Oncology, Ali Ebn-e Abitaleb Hospital Research Center For Children And Adolescents Health [RCCAH], Zahedan University of Medical Sciences, Zahedan, IR Iran
0031947532846001011
0031947532846001011
No
Shadi
Tabibian
Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, IR Iran
0031947532846001012
0031947532846001012
No
Maryam Sadat
Hosseini
Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, IR Iran
0031947532846001013
0031947532846001013
No
Shaban
Alizadeh
Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, IR Iran
0031947532846001014
0031947532846001014
No
Soudabeh
Hosseini
Department of Hematology, Allied Medical School, Iran University of Medical Sciences, Tehran, IR Iran
0031947532846001015
0031947532846001015
No
Hossein
Karami
Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran
0031947532846001016
0031947532846001016
No
Hassan
Mahmoodi Nesheli
Non- Communicable Pediatric Disease Research Center, Babol University of Medical Sciences, Babol, Iran
0031947532846001017
0031947532846001017
No
Akbar
Dorgalaleh
Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, IR Iran
0031947532846001018
0031947532846001018
Yes
en
Management of Lower Respiratory Tract Illnesses in Developing Countries: A Narrative Review
Pneumonia is the leading cause of mortality in young children worldwide. Early diagnosis and empiric antibacterial therapy is an important strategy to improve outcome. The World Health Organization (WHO) has developed case management guidelines to reduce pneumonia-related deaths through early diagnosis and antibiotic treatment. For management purpose, pneumonia is subclassified by its severity. Children with simple pneumonia, pneumonia with chest wall in-drawing or pneumonia with danger signs (convulsion, cyanosis, inability to drink, abnormal sleepiness). Pneumonia with danger signs requires hospitalization and parenteral antibiotics, whereas children who only have fast breathing (tachypnea) can be treated at home with oral antibiotics. Later, these strategies were incorporated into the Integrated Management of Childhood Illnesses (IMCI), and the protocol was adopted by several developing countries. Despite the proven benefit of this program in reducing pneumonia-related deaths, there has been some concern about the specificity of the WHO and the IMCI guidelines, leading to unnecessary use of antibiotic for children with tachypnea, who were categorized as pneumonia. There is a necessity to improve the IMCI case management of childhood pneumonia because of overlap with other lower respiratory tract illnesses. This review outlines current guidelines for childhood pneumonia management in developing countries and identifies challenges for improvement in management in a variety of settings.
Pneumonia, Respiratory Tract Diseases, Developing Countries
47
56
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-30-21&slc_lang=en&sid=1
2014/06/182014/06/242014/02/262014/07/152014/05/19
1393/2/29
2014/08/172014/08/32014/06/32014/07/152014/07/14
1393/4/23
Mohammad Jafar
Saffar
Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Sciences, Sari, Iran
saffar@softhome.net
0031947532846001019
0031947532846001019
Yes
Mohammad Sadegh
Rezai
Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Sciences, Sari, Iran
0031947532846001020
0031947532846001020
No
en
Vitamin E in children with asthma: A review
Asthma is a chronic inflammatory airway disorder and the most common chronic disease among children characterized by frequent and chronic cough, wheezing, and dyspnea. Asthma is defined as an inflammatory process in response to T- Helper 2 cells. Vitamin E as a Lipid soluble vitamin containing 4 isomers α, β, γ, б, with α- tocopherol as the most important isomer is an important defensive agent against epithelial tissue damages caused by antioxidants in human. The results of animal studies showed vitamins C and E cause decreased and modulation of pulmonary responses to oxidant agents such as O3 or NO2. A few studies showed an association between reduced intake of vitamin E by mothers during pregnancy and wheezing in children aged 2 years old. Some studies showed significant declines in serum vitamin E level in asthmatic children compared to non-asthmatic. However, in another study no significant relationship was observed between serum level of vitamin E and risk of asthma. There are controversies on the effect of vitamin E in children with asthma. This study aimed to investigate the role of vitamin E in children with asthma.
Vitamin E, Asthma, Child
57
65
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-30-23&slc_lang=en&sid=1
2014/06/182014/06/242014/02/262014/07/152014/05/192014/06/18
1393/3/28
2014/08/172014/08/32014/06/32014/07/152014/07/142014/08/8
1393/5/17
Javad
Ghaffari
Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Sciences, Sari, Iran
javadneg@yahoo.com
0031947532846001021
0031947532846001021
Yes
Hossein
Ashrafi
Beatson Institute for Cancer Research, Faculty of Medicine, University of Glasgow, UK
0031947532846001022
0031947532846001022
No
Ali Reza
Ranjbar
Research Institute of Interventional Allergology and Immunology, Bonn/Cologne, Germany
0031947532846001023
0031947532846001023
No
Zeinab
Nazari
Department of Obstetric & Gynecologist, Mazandaran University of Medical Sciences, Sari, Iran
0031947532846001024
0031947532846001024
No
en
Use of Ribavirin treatment in Pre-transplant patients with Respiratory Syncytial Virus Upper Respiratory Tract Infection: Case report and Review of Literature
Respiratory syncytial virus infection in immunocompromised patients, especially those with defects in cell mediated immunity is associated with high morbidity and mortality. Lymphocytopenia is an important factor associated with progression of upper to lower respiratory tract infection. The only licensed antiviral treatment for RSV available currently is ribavirin, although additional immunomodulatory therapies may also play a beneficial role. The use of ribavirin in immunocompromised patients with lower respiratory tract infection has some evidence for efficacy in reducing mortality. We report two cases of pre-transplant patients with acute myeloid leukaemia who were considered for ribavirin treatment for RSV upper respiratory tract infection and review the published literature on this. The use of ribavirin in immunocompromised patients with RSV upper respiratory tract infection to reduce the risk of progression to lower respiratory tract infection is unclear. In patients with Respiratory syncytial virus upper respiratory tract infection detected in the pre-haematopoetic stem cell transplant stage, delay of transplantation remains the most effective method of reducing morbidity and mortality.
respiratory syncytial virus, ribavirin, immunosuppressed
66
71
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-263-1&slc_lang=en&sid=1
2014/06/182014/06/242014/02/262014/07/152014/05/192014/06/182014/07/15
1393/4/24
2014/08/172014/08/32014/06/32014/07/152014/07/142014/08/82014/08/10
1393/5/19
Ameneh
Khatami
Department of Infectious Diseases and Microbiology, The Children’s Hospital at Westmead, New South Wales, Australia
ameneh.khatami@health.nsw.gov.au
0031947532846001025
0031947532846001025
Yes
en
Eradication of Helicobacter pylori with triple therapy regimen (omeprazole, clarithromycin and amoxicillin) in children for seven days (A Pilot Study)
Background and purpose: Successful treatment of Helicobacter pylori infection causes not only eradication of pathogen, but also prevents the associated diseases such as peptic ulcer, gastric carcinoma and lymphoma. The aim of this study was to evaluate the efficacy of 7 days triple therapy as a lowest drug resistance, shortest duration and fewer numbers of drugs in children.
Materials and Method: The target population was 22 children <15 years with peptic disease complaints. The inclusion criteria were: positive endoscopic finding, inflammatory evidence in gastric biopsy and presence of Helicobacter pylori in gastric mucosa. Two pieces from incisura and body of gastric mucosa were taken and stained with Gimsa. Helicobacter pylori positive patients were treated with omeprazol, clarithromycin and amoxicillin for 7 days. One month later, all cases were evaluated by repeated endoscopy or Urea Breath Test and H pylori eradication were assessed. Data was gathered and analyzed with SPSS software, and McNamara's and Chi-Square test were performed. Results: Nineteen patients were studied including twelve boys, 26.3% 2-6 years and the rest older than 6 years. The most common clinical presentations and endoscopic findings were chronic abdominal pain (74%) and nodularity (47.4%), respectively. The per-protocol and intention-to-treat H. pylori eradication rates were 84.2% and 76%, respectively in seven days triple therapy regimen.
Conclusion: Seven days triple therapy successfully eradicated H pylori in children.
Helicobacter pylori, Eradication therapy, child, Omeprazol, Clarithromycin, Amoxicillin
72
77
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-94-1&slc_lang=en&sid=1
2014/06/182014/06/242014/02/262014/07/152014/05/192014/06/182014/07/152014/05/3
1393/2/13
2014/08/172014/08/32014/06/32014/07/152014/07/142014/08/82014/08/102014/08/17
1393/5/26
Mehri
Najafi
Children Medical Center Hospital, Tehran University of Medical Sciences, Tehran-Iran
najafia@sina.tums.ac.ir
0031947532846001026
0031947532846001026
No
Fariba
Seighali
Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran-Iran
fseighali@yahoo.com
0031947532846001027
0031947532846001027
Yes
en
Letter to Editor
No Abstract
Mental health status, Thalassemia, Iran
78
79
http://jpr.mazums.ac.ir/browse.php?a_code=A-10-94-2&slc_lang=en&sid=1
2014/06/182014/06/242014/02/262014/07/152014/05/192014/06/182014/07/152014/05/32014/08/17
1393/5/26
2014/08/172014/08/32014/06/32014/07/152014/07/142014/08/82014/08/102014/08/172014/08/19
1393/5/28
Mehrnoush
Kosaryan
Thalassemia Research Center, Mazandaran University of Medical Sciences, Sari, Iran
mekowsarian@gmail.com
0031947532846001028
0031947532846001028
Yes